Donaldson (DCI) Insider Filing: Grant of 5,942 Shares and Small Sale
Rhea-AI Filing Summary
Richard B. Lewis, President of DONALDSON Co Inc (DCI), reported changes in beneficial ownership on 09/25/2025. The filing shows indirect holdings of 832 and 3,866 shares held by a benefit plan trust. On 09/25/2025 the reporting person recorded an acquisition of 5,942 common shares (price shown as $0) and a separate disposition of 140 common shares at $80.04. Following the reported transactions the filing lists direct beneficial ownership balances of 39,919 and 39,779 shares in successive lines, reflecting the net holdings reported after each transaction.
Positive
- Officer received equity (5,942 shares at $0), indicating compensation alignment with shareholders
- Disclosure includes indirect benefit plan trust holdings, improving transparency about total insider exposure
Negative
- Reported sale of 140 shares at $80.04 reduces direct holdings, though amount is small
- Price of acquisition shown as $0 lacks context in the filing about grant terms or vesting
Insights
TL;DR: Routine insider equity grant and minor sale by the company president; typical governance disclosure.
The Form 4 discloses an officer-level insider, Richard B. Lewis, receiving 5,942 common shares (price reported as $0), consistent with a non-cash equity grant or similar award, and a small sale of 140 shares at $80.04. Holdings include indirect shares via a benefit plan trust. These are standard Section 16 disclosures that increase transparency about insider compensation and liquidity activity. No unusual concentrations, pledges, or derivative positions are reported.
TL;DR: Transactions are small relative to typical insider positions; informational for modeling insider confidence but not material.
The reported acquisition at a $0 price likely represents an equity award rather than an open-market purchase; the sale of 140 shares at $80.04 is immaterial in size. The filing shows both direct and indirect ownership components, useful for calculating total insider stake. No options, warrants, or derivative activity is disclosed in Table II. This filing does not present new operating metrics or balance-sheet impacts.